Pathological stage Active surveillance Recurrence or relapse Antibody drug conjugate Minimal residual disease Cure Tumor Adjuvant treatment Liquid tumor Performance status Partial remission Maintenance chemotherapy CTCAE Leukemia Complementary therapy Chemotherapy Tyrosine kinase inhibitors (TKIs) Grade 3, 4, or 5 Neoadjuvant treatment TNM staging system PET scan Clinical stage Sarcoma Cancer Adenocarcinoma Complete remission Benign Refractory Definitive treatment ECOG performance status Lymphoma Carcinoma Cellular therapy Monoclonal antibody Palliation Surgical margin Multiple myeloma Checkpoint inhibitor Pathological stage Active surveillance Recurrence or relapse Antibody drug conjugate Minimal residual disease Cure Tumor Adjuvant treatment Liquid tumor Performance status Partial remission Maintenance chemotherapy CTCAE Leukemia Complementary therapy Chemotherapy Tyrosine kinase inhibitors (TKIs) Grade 3, 4, or 5 Neoadjuvant treatment TNM staging system PET scan Clinical stage Sarcoma Cancer Adenocarcinoma Complete remission Benign Refractory Definitive treatment ECOG performance status Lymphoma Carcinoma Cellular therapy Monoclonal antibody Palliation Surgical margin Multiple myeloma Checkpoint inhibitor
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
Pathological stage
Active surveillance
Recurrence or relapse
Antibody drug conjugate
Minimal residual disease
Cure
Tumor
Adjuvant treatment
Liquid tumor
Performance status
Partial remission
Maintenance chemotherapy
CTCAE
Leukemia
Complementary therapy
Chemotherapy
Tyrosine kinase inhibitors (TKIs)
Grade 3, 4, or 5
Neoadjuvant treatment
TNM staging system
PET scan
Clinical stage
Sarcoma
Cancer
Adenocarcinoma
Complete remission
Benign
Refractory
Definitive treatment
ECOG performance status
Lymphoma
Carcinoma
Cellular therapy
Monoclonal antibody
Palliation
Surgical margin
Multiple myeloma
Checkpoint inhibitor